Strategic Partnerships

Avantra Biosciences

Avantra Biosciences is a privately held diagnostics company that has pioneered next-generation technology for protein biomarker analysis. Initially focused on oncology, Avantra's integrated system enables scientists and clinicians to perform multiplex biomarker analysis for research use only (RUO) from their lab bench or clinical trial site.

http://www.avantrabio.com/

Dell

Dell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services they trust and value. Uniquely enabled by its direct business model, Dell is a leading global systems and services company and No. 34 on the Fortune 500. For more information, visit www.dell.com, or to communicate directly with Dell via a variety of online channels, go towww.dell.com/conversations. To get Dell news direct, visit www.dell.com/RSS.

http://www.dell.com

National Foundation for Cancer Research

The National Foundation for Cancer Research (NFCR) was founded in 1973 to support cancer research and public education relating to the prevention, early diagnosis, better treatments and ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. NFCR is committed to Research for a Cure- Cures all types of cancers.

http://www.nfcr.org

START Center for Cancer Care

The Mission of START Center for Cancer Care is to provide quality research, diagnosis and treatment of cancers for the community of patients and clients we serve.

START Center for Cancer Care offers a full range of treatment options for patients facing cancer treatment. We specialize in Medical Oncology, Hematology, Gynecologic Oncology, and Radiation Oncology, and our physicians stand ready to treat you with a full range of therapies including the most current research protocols. With over 100 years of combined experience, our staff is well equipped to help you and your family during your treatment regimen.

http://www.stoh.com

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information to better manage the cost and quality of healthcare and accelerate scientific research and innovation. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. DRUGDEX®, the Thomson Reuters drug compendium provided within Oncocentric, is the most comprehensive source of referenced drug information for evidence-based practice and a recognized standard for drug utilization review and screening. DRUGDEX® provides additional validation of clinicians' chosen treatments from a recognized reference standard for Medicare Parts B and D and for Medicaid.

http://thomsonreuters.com/

Translational Genomics Research Institute

The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments.

Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.

http://www.tgen.org

MedTrust Online is always seeking partners to complement our comprehensive physician portal. The MedTrust Online solution designed to help oncologists with therapeutic decisions at the time of diagnosis is also proving equally valuable for pharmaceutical, biotech and medical device companies as well as physician groups, publishers and other business entities.

Contact MedTrust Online to begin the process of becoming a strategic partner.